Sunflower Pharmaceutical Group Co., Ltd. (SHE:002737)

SHE:002737 Revenue

Sunflower Pharmaceutical Group had revenue of 654.04M CNY in the quarter ending June 30, 2026, with 1.14% growth. This brings the company's total for the last twelve months to 2.51B, up 16.03% year-over-year. In the year 2025, Sunflower Pharmaceutical Group had annual revenue of 2.32B, down -31.36%. That makes Sunflower Pharmaceutical Group the 12,980th largest company in the world by revenue and 2,254th in China.

• Revenue (ttm): 2.51B
• Revenue Growth: +16.03%
• P/S Ratio: 2.62
• Revenue / Employee: 498.66K
• Employees: 5,025
• Market Cap: 6.56B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Medicine 3.65B 91.7%
• Other 331.59M 8.3%

Fiscal year ended Dec 31, 2025 See the full SHE:002737 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.32B	-1.06B	-31.36%
Dec 31, 2024	3.38B	-2.32B	-40.76%
Dec 31, 2023	5.70B	605.78M	11.89%
Jan 1, 2023	5.09B	633.61M	14.20%
Jan 1, 2022	4.46B	999.01M	28.86%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error